Redmile Group, LLC's Form 4 filing
IGM Biosciences, Inc. (IGMS) · filed Jul 3, 2023
- Accession no.
- 0001104659-23-077730
- Filed
- Jul 3, 2023, 9:45 PM ET
- Trade date
- Jun 29-30, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market purchases total $757.6K. Open-market sales total $757.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Redmile Group, LLCCIK 0001425738 | Director |
| Green JeremyCIK 0001650527 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2023 | Common Stock | SSaleDisposed | −80,423 | $9.42 | −$757,584.66 | 2,893,763 | Indirect | |
| Jun 29, 2023 | Common Stock | PPurchaseAcquired | +80,423 | $9.42 | +$757,584.66 | 2,974,186 | Indirect | |
| Jun 29, 2023 | Common Stock | JOtherDisposed | −54,740 | $9.42 | −$515,650.8 | 2,919,446 | Indirect | |
| Jun 29, 2023 | Common Stock | JOtherAcquired | +54,740 | $9.42 | +$515,650.8 | 2,974,186 | Indirect | |
| Jun 30, 2023 | Common Stock | AGrant or awardAcquired | +492 | $0.00 | $0 | 2,974,678 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.